Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/key394
PubMed Identifier: 30590695
Publication URI: http://europepmc.org/abstract/MED/30590695
Type: Journal Article/Review
Volume: 58
Parent Publication: Rheumatology (Oxford, England)
Issue: 5
ISSN: 1462-0324